Illumina/GRAIL: A Short Note on the European Commission’s Order to Unwind the Deal

Concurrences Law Review, 1-2024 (March 2024)

2 Pages Posted: 2 Feb 2024 Last revised: 11 Feb 2024

See all articles by Simon Vande Walle

Simon Vande Walle

University of Tokyo - Graduate Schools for Law and Politics

Date Written: February 10, 2024

Abstract

A short note on the Commission’s decision to unwind Illumina’s acquisition of GRAIL.

The decision is the denouement – literally and figuratively – of the long saga triggered by Illumina’s attempt to acquire GRAIL. The European Commission ordered Illumina to unwind its acquisition of GRAIL, one of several companies engaged in an innovation race to develop a multi-cancer early detection test, the “holy grail” (hence the company’s name) of cancer research.

Decision commented: Case M. 10939 - Illumina / GRAIL (Restorative measures under Article 8(4)a), Decision of 12 October 2023

Keywords: antitrust law, competition law, merger control

JEL Classification: K21

Suggested Citation

Vande Walle, Simon, Illumina/GRAIL: A Short Note on the European Commission’s Order to Unwind the Deal (February 10, 2024). Concurrences Law Review, 1-2024 (March 2024), Available at SSRN: https://ssrn.com/abstract=4709710 or http://dx.doi.org/10.2139/ssrn.4709710

Simon Vande Walle (Contact Author)

University of Tokyo - Graduate Schools for Law and Politics ( email )

7-3-1 Hongo Bunkyo-Ku
Tokyo, 113-0033
Japan

HOME PAGE: http://www.simonvandewalle.eu

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
50
Abstract Views
125
PlumX Metrics